The physicians at Mount Nittany Physician Group - Urology are dedicated to providing high quality care and improving the urologic health of our patients. This includes the ability to offer our patients further treatment options with the newest investigational medications and treatments being researched today. Clinical Research provides the patients in our community with access to cutting edge treatments, which may not otherwise be available to them.
New medicines, treatment options and technology are being introduced everyday to help improve our quality of life. You or a loved on may be asked to consider participating in a research study to evaluate these potential breakthroughs in medical science. Participating as a study volunteer is one way to contribute to the advancement of medical research.
A "clinical trial" is a type of research study or scientific investigation that is done to help doctors learn more about new ways to prevent, diagnose or treat a disease. This type of research involves human beings who choose to volunteer to participate in the research study. The research study may also be done to find out if the drug or device being researched is safe and effective for people to use.
The participants in research studies perform a very valuable service. However, before enrolling, it is a good idea to know what is expected and what is going to take place throughout the clinical trial. Be sure to ask questions and discuss any concerns you might have with the research staff.
To learn more about research and clinical trials available at Mount Nittany Physician Group - Urology, call 814.272.3139 today.
You may also find out more information about volunteering for a clinical trial by clicking on the links below:
Now enrolling: clinical research study for metastatic prostate cancer.
You're fighting back. We're working to enhance your body's ability to do the same. The PROSPECT study is evaluating the potential effectiveness of an investigational vaccine-based immunotherapy for metastatic prostate cancer. The investigational vaccine - administered through a series of injections over a period of five months - is designed to teach the body's immune system to identify and destroy prostate cancer cells. To learn more, contact Karen Smith, RN, Clinical Research Coordinator, at 814.238.8418 x206 or firstname.lastname@example.org.
Visit ContinueYourFight.com and clinicaltrial.gov/prostatecancer.
Overactive Bladder: A0221095 Study
Bladder Cancer Study
A Phase 3, randomized, active-controlled, open-label, multicenter study to evaluate the efficacy and safety of EN3348 (MCC) as compared with mitomycin C in the intravesical treatment of subjects with BCG Recurrent or Refractory Non-Muscle Invasive Bladder Cancer. This study will consist of 4 phases: Screening, Induction, Maintenance and Follow-Up and will be conducted over 3 years. To learn more, contact Karen Smith, RN, Clinical Research Coordinator, at 814.238.8418 x206 or email@example.com.